Network origin in Wenji Chen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.
21
| Subsidiary | Pharmaceuticals: Major | 21 |
| Subsidiary | Pharmaceuticals: Major | 7 | |
GlaxoSmithKline (China) R&D Co., Ltd.
2
| Subsidiary | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Wenji Chen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
General Atlantic LLC
 General Atlantic LLC Investment ManagersFinance General Atlantic LLC (General Atlantic) is a private equity firm founded in 1980 by Charles F. Feeney. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Longwood Fund LP
 Longwood Fund LP Investment ManagersFinance Longwood Fund LP invests in companies located in the US. The fund targets companies operating in the fields healthcare companies. It provides financing for early stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
| RA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Wake Forest University | College/University | Doctorate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree | |
| University of California, Riverside | College/University | Masters Business Admin | |
| University of Michigan | College/University | Corporate Officer/Principal | |
| Western Carolina University | College/University | Undergraduate Degree | |
Ma Laboratories, Inc.
 Ma Laboratories, Inc. Electronics DistributorsDistribution Services Ma Laboratories, Inc. distributes computer components and other consumer electronics. It offers selection of memory, storage products and other hardware and software components for PCs and servers, and consumer electronics. The firm products include CPUs, storage devices, notebooks, motherboards, graphics cards, displays, wireless networking, cases, consumer electronics, software and more. The company was founded in 1983 and is headquartered in San Jose, CA. | Electronics Distributors | Comptroller/Controller/Auditor | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| National Taiwan University | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
| IBIO, INC. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| CELYAD ONCOLOGY SA | Biotechnology | Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| G1 THERAPEUTICS, INC. | Pharmaceuticals: Major | President | |
OxOnc Development LP
 OxOnc Development LP BiotechnologyHealth Technology OxOnc Development LP operates as an oncology development company. It offers a drug development model that is based on the expertise and core competencies to design and execute clinical trials in oncology. The firm's business model is an integration of scientific, clinical, operational and financial resources, and provides a value-add proposition to its co-development partner by providing a profit and loss-sparing mechanism to fund research and development efforts externally. The company was founded in 2012 and is headquartered in George Town, Cayman Islands. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
| ABZENA PLC | Biotechnology | Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member | |
| AP BIOSCIENCES INC | Biotechnology | Director/Board Member Chairman | |
Fog Pharmaceuticals, Inc.
 Fog Pharmaceuticals, Inc. BiotechnologyHealth Technology Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| TLC Biopharmaceuticals, Inc. | Comptroller/Controller/Auditor | ||
| Nirvan Consultants LLC | President | ||
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Chairman | |
Axial Therapeutics, Inc.
 Axial Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Axial Therapeutics, Inc. provides biopharmaceuticals. It is harnessing the link between the human get microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders. The company was founded by Sarkis Mazmanian and David H. Donabedian and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chief Executive Officer | |
| FORMOSA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
PathAI, Inc.
 PathAI, Inc. Packaged SoftwareTechnology Services PathAI, Inc. provides artificial intelligence powered technology for the pathology laboratory. It offers research and drug development, clinical and global health solutions. The firm specializes in pathology, digital pathology, oncology, immune-oncology, auto immune disease, neurodegenerative disease, companion diagnostics, precision medicine, solutions, research and development and computational pathology. The company was founded by Andrew H. Beck and Aditya Khosla in 2016 and is headquartered in Cambridge, MA. | Packaged Software | Director/Board Member | |
Aelin Therapeutics NV
 Aelin Therapeutics NV Pharmaceuticals: MajorHealth Technology Aelin Therapeutics NV develops drugs for antibiotics and first-in-class therapeutics. The company is based in Leuven, Belgium. The Belgian company was founded in 2017. The CEO is Els Beirnaert. | Pharmaceuticals: Major | Director/Board Member | |
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Biotechnology | Founder | |
Rgenta Therapeutics, Inc.
 Rgenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Rgenta Therapeutics, Inc. manufactures medicines for oncology and neurological disorders. The company was founded by Simon Xi, Travis Wager, and Zhiping Weng and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chairman | |
Biospring Management Partners LP
 Biospring Management Partners LP Investment ManagersFinance Biospring Management Partners LP (Biospring Partners) is a venture capital firm founded in 2020 by Michelle Dipp and Jennifer Lumba. The firm is headquartered in New York. | Investment Managers | Founder | |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology T-Knife GmbH operates as an next-generation adoptive T-cell company using its proprietary humanized T-cell receptor mouse platform to treat solid tumors. The company was founded by Thomas Blankenstein, Elisa Kieback and Holger Specht in 2018 and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
Monopteros Therapeutics, Inc.
 Monopteros Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Monopteros Therapeutics, Inc. manufactures pharmaceuticals. | Pharmaceuticals: Major | Director/Board Member | |
Kiniciti
 Kiniciti Information Technology ServicesTechnology Services Kiniciti is a platform company that invests in and partners with companies to strengthen the cell and gene therapy ecosystem. The company, which is based in New York, NY, was founded by Geoffrey Michael Glass, who has been the CEO since incorporation. Kiniciti is backed by private equity firm Welsh, Carson, Anderson & Stowe (WCAS) and Biospring Partners. The company offers a highly tailored, collaborative, and flexible investment and strategic support model to ensure the promise of cell and gene therapeutics is delivered quickly and safely to patients worldwide. The leadership team includes professionals experienced in investing in and building successful companies across the life sciences sector. | Information Technology Services | Director/Board Member | |
Incyclix Bio LLC
 Incyclix Bio LLC Pharmaceuticals: MajorHealth Technology Incyclix Bio, Inc., formerly known as Arc Therapeutics, is a pharmaceutical company that focuses on developing small molecule inhibitors of cyclin-dependent kinases (CDKs) to treat advanced and resistant cancers. The company is based in Durham, NC. The company's team has unique insights into the biology and structure of CDKs, which will facilitate the rapid discovery and development of a novel, potent, and selective Cdk2 inhibitor. Incyclix Bio was founded by industry experts with robust drug design, discovery, and development experience, including Patrick Roberts, John Bisi, Fredric N. Eshelman, and Jay C. Strum. Patrick Roberts has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures LLC (Third Rock Ventures) is a venture capital firm founded in 2007 by Mark Levin, Robert Tepper, Kevin Starr and Nick Leschly. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor |
Statistics
International
| United States | 37 |
| Taiwan | 4 |
| United Kingdom | 3 |
| France | 3 |
| Belgium | 3 |
Sectoral
| Health Technology | 32 |
| Consumer Services | 8 |
| Finance | 6 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 122 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 39 |
| Chief Tech/Sci/R&D Officer | 33 |
| Chairman | 31 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Hong Jen Chang | 34 |
| Michelle Dipp | 22 |
| David Stout | 19 |
| Debasish Francois Roychowdhury | 18 |
| Barbara Weber | 16 |
| Anne Phillips | 14 |
| June Almenoff | 14 |
| Yi-Xin Wang | 13 |
| Paul Bolno | 12 |
| Hung Ta Lin | 11 |
| George Spencer-Green | 11 |
| John Pottage | 10 |
| Ju Yi Lin | 9 |
| Mao Jung Lin | 9 |
- Stock Market
- Insiders
- Wenji Chen
- Company connections